Median IL-5 serum levels were significantly higher in SSc patients compared to HC [15.73 ng/ml (IQR 11.65–19.24) vs 5.93 ng/ml (IQR 4.46–6.61), p < 0.001]. This evidence concerns the gene IL5 and systemic sclerosis.